Effects of the simultaneous use of drug-eluting stents and statins in an atherosclerotic animal model

Lloyd-Jones, 2009, Heart Disease and Stroke Statistics—2009 Update. A Report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee, Circulation, 119, e21, 10.1161/CIRCULATIONAHA.108.191261 Brown, 2006, Simultaneous low-density lipoprotein-C lowering and high-density lipoprotein-C elevation for optimum cardiovascular disease prevention with various drug classes, and their combinations: a meta-analysis of 23 randomized trials, Curr Opin Lipidol, 17, 631, 10.1097/MOL.0b013e32800ff750 Law, 2003, Quantifying effects of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis, BMJ, 326, 1423, 10.1136/bmj.326.7404.1423 2005, Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins, Lancet, 366, 1267, 10.1016/S0140-6736(05)67394-1 Bulbulia, 2007, MRC/BHF Heart Protection Study (HPS): mortality, cancer incidence and major vascular events during 4 years post-trial follow-up of HPS, J Am Coll Cardiol, 49, 393 Law, 2003, Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis, BMJ, 326, 1423, 10.1136/bmj.326.7404.1423 Balamuthusamy, 2007, Statins decrease the risk of acute myocardial infarction and coronary heart disease mortality in patients with renal failure, J Am Coll Cardiol, 49, 188 Saha, 2007, Statins reduce the risk of death and the occurrence of adverse cardiovascular events in patients with dyslipidemia and renal dysfunction: a meta-analysis of randomized placebo-controlled trials, Am J Cardiol, 49, 344 Nissen, 2004, Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial, JAMA, 291, 1071, 10.1001/jama.291.9.1071 Nissen, 2006, Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial, JAMA, 295, 1556, 10.1001/jama.295.13.jpc60002 Windecker, 2000, Intervention in coronary artery disease, Heart, 83, 481, 10.1136/heart.83.4.481 Stettler, 2007, Outcomonth associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis, Lancet, 370, 937, 10.1016/S0140-6736(07)61444-5 Kastrati, 2005, Sirolimus-eluting stents vs. paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials, JAMA, 294, 819, 10.1001/jama.294.7.819 Kereiakes, 2005, Surrogates, substudies, and real clinical end points in trials of drug-eluting stents, J Am Coll Cardiol, 45, 1206, 10.1016/j.jacc.2005.01.005 Stone, 2008, Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease. A randomized trial, JAMA, 299, 1903, 10.1001/jama.299.16.1903 Eisenberg, 2006, Review of randomized clinical trials of drug-eluting stents for the prevention of in-stent restenosis, Am J Cardiol, 98, 375, 10.1016/j.amjcard.2006.02.042 Joner, 2006, Pathology of drug-eluting stents in humans. Delayed healing and late thrombotic risk, J Am Coll Cardiol, 48, 193, 10.1016/j.jacc.2006.03.042 Echeverri, 2008, Estabilização da placa aterosclerótica por stents farmacológicos e não-farmacológicos em modelo experimental de fibroateroma de capa fina em coelhos, Rev Bras Cardiol Invas, 16, 170 Levine, 2006, Pharmacotherapy, 26, 1537, 10.1592/phco.26.11.1537 Schwartz, 1992, Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model, J Am Coll Cardiol, 19, 267, 10.1016/0735-1097(92)90476-4 1996 Schwartz, 2001, Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromonth: the MIRACL study: a randomized controlled trial, JAMA, 285, 1711, 10.1001/jama.285.13.1711 Cannon, 2004, Intensive versus moderate lipid lowering with statins after acute coronary syndromonth, N Engl J Med, 350, 1495, 10.1056/NEJMoa040583 1994, Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS), Lancet, 344, 633, 10.1016/S0140-6736(94)92082-6 Okazaki, 2004, Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH study, Circulation, 110, 1061, 10.1161/01.CIR.0000140261.58966.A4 Hong, 2009, Virtual histology intravascular ultrasound analysis effects of statin treatments on coronary plaques assessed by volumetric, J Am Coll Cardiol Intv, 2, 679, 10.1016/j.jcin.2009.03.015 Hirayama, 2009, Qualitative and quantitative changes in coronary plaque associated with atorvastatin therapy, Circ J, 73, 718, 10.1253/circj.CJ-08-0755 Corti, 2001, Effects of lipid-lowering by simvastatin on human atherosclerotic lesions a longitudinal study by high-resolution, noninvasive magnetic resonance imaging, Circulation, 104, 249, 10.1161/01.CIR.104.3.249 Shiomi, 2001, Fibromuscular cap composition is important for the stability of established atherosclerotic plaques in mature WHHL rabbits treated with statins, Atherosclerosis, 157, 75, 10.1016/S0021-9150(00)00708-5 Sollott, 1995, Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat, J Clin Invest, 95, 1869, 10.1172/JCI117867 Drachman, 2000, Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over 6 months, J Am Coll Cardiol, 36, 2325, 10.1016/S0735-1097(00)01020-2 Echeverri, 2004, Reducción del colesterol sérico y su repercusión en los efectos pleiotrópicos y morfológicos en placas ateroescleróticas tempranas en un modelo animal: Implicaciones en el tratamiento y prevención de la ateroesclerosis, Rev Col Cardiol, 11, 57 Pucci, 2007, In vivo coronary plaque histology in patients with stable and acute coronary syndromonth: relationships with hyperlipidemic status and statin treatment, Atherosclerosis, 194, 189, 10.1016/j.atherosclerosis.2006.07.026 Libby, 2002, Inflammation and atherosclerosis, Circulation, 105, 1135, 10.1161/hc0902.104353 Ridker, 2002, Comparison of C-reactive protein and LDL-cholesterol in the prediction of first cardiovascular events, N Engl J Med, 347, 1557, 10.1056/NEJMoa021993 Mueller, 2002, Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients, Circulation, 105, 1412, 10.1161/01.CIR.0000012625.02748.62 Danenberg, 2002, Macrophage depletion by clodronate-containing liposomonth reduces neointimal formation after balloon injury in rats and rabbits, Circulation, 106, 599, 10.1161/01.CIR.0000023532.98469.48 Farb, 2002, Morphological predictors of restenosis after coronary stenting in humans, Circulation, 105, 2974, 10.1161/01.CIR.0000019071.72887.BD Kereiakes, 2003, Adjunctive pharmacotherapy before percutaneous coronary intervention in non-st-elevation acute coronary syndromonth: the role of modulating inflammation, Circulation, 108, III-22 Gaspardone, 2002, Effect of atorvastatin (80mg) initiated at the time of coronary artery stent implantation on C-reactive protein and six-month clinical events, Am J Cardiol, 90, 786, 10.1016/S0002-9149(02)02615-2 Pasceri, 2004, Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention results from the ARMYDA (Atorvastatin for Reduction of Myocardial Damage during Angioplasty) Study, Circulation, 110, 674, 10.1161/01.CIR.0000137828.06205.87 Moscucci, 2002, Effect of pre-procedure lipid lowering therapy on inhospital mortality following percutaneous coronary interventions: an analysis of a large multicenter database, J Am Coll Cardiol, 39, 32A, 10.1016/S0735-1097(02)80139-5 Schömig, 2002, Statin treatment following coronary artery stenting and one-year survival, J Am Coll Cardiol, 40, 854, 10.1016/S0735-1097(02)02053-3 Briguori, 2009, Impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction, J Am Coll Cardiol, 54, 2157, 10.1016/j.jacc.2009.07.005 Di Sciascio, 2009, Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial, J Am Coll Cardiol, 54, 558, 10.1016/j.jacc.2009.05.028 Prati, 2007, The RESTART Project: high-dose atorvastatin helps control Restenosis After Stenting procedures at high risk for restenosis. Results from a prospective study and a matched control group comparison, EuroIntervention, 3, 89